Patents by Inventor Won Sik Eum

Won Sik Eum has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Protein transduction domain, fusion compound containing the same, and pharmaceutical composition containing the fusion compound
    Patent number: 11661464
    Abstract: A protein transduction domain and a fusion compound, which are more efficient, are proposed. As a result of selecting and testing a number of candidate peptides, the present inventors found that a GK1 peptide comprising 18 amino acids and a modified sequence obtained by replacing, adding, or deleting some sequences are bonded to high-molecular-weight materials such as proteins based on the basic sequence of the peptide, thus enabling the high-molecular-weight materials to smoothly penetrate into living bodies, for example, cells, tissues, or blood. A fusion compound, oligonucleotide, or vector using the same may be applied as a pharmaceutical composition for preventing or treating diseases.
    Type: Grant
    Filed: October 30, 2020
    Date of Patent: May 30, 2023
    Assignee: Genesen Co., Ltd.
    Inventors: Soo-Young Choi, Jin-Seu Park, Kyuhyung Han, Keunwook Lee, Jong Kook Park, Sunghou Lee, Sung Ho Lee, Soojung Park, Won Sik Eum, Min Jea Shin, Hyeon Ji Yeo, Eun Ji Yeo, Yeon Joo Choi, Eun Jeong Sohn, Hyun Ju Cha, Hyun Jung Kwon, Dae Won Kim
  • PROTEIN TRANSDUCTION DOMAIN, FUSION COMPOUND CONTAINING THE SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE FUSION COMPOUND
    Publication number: 20210355240
    Abstract: A protein transduction domain and a fusion compound, which are more efficient, are proposed. As a result of selecting and testing a number of candidate peptides, the present inventors found that a GK1 peptide comprising 18 amino acids and a modified sequence obtained by replacing, adding, or deleting some sequences are bonded to high-molecular-weight materials such as proteins based on the basic sequence of the peptide, thus enabling the high-molecular-weight materials to smoothly penetrate into living bodies, for example, cells, tissues, or blood. A fusion compound, oligonucleotide, or vector using the same may be applied as a pharmaceutical composition for preventing or treating diseases.
    Type: Application
    Filed: October 30, 2020
    Publication date: November 18, 2021
    Inventors: Soo-Young CHOI, Jin-Seu PARK, Kyuhyung HAN, Keunwook LEE, Jong Kook PARK, Sunghou LEE, Sung Ho LEE, Soojung PARK, Won Sik EUM, Min Jea SHIN, Hyeon Ji YEO, Eun Ji YEO, Yeon Joo CHOI, Eun Jeong SOHN, Hyun Ju CHA, Hyun Jung KWON, Dae Won KIM
  • Eye drop composition for prevention and treatment of ophthalmic diseases containing fusion protein of FK506 binding protein
    Patent number: 8962567
    Abstract: Disclosed is a treatment for ophthalmic diseases, more specifically, a pharmaceutical composition for treating ophthalmic diseases including a fusion protein of FK506 binding protein capable of penetrating into the ocular tissue as an active ingredient.
    Type: Grant
    Filed: April 6, 2011
    Date of Patent: February 24, 2015
    Assignee: Industry Academic Cooperation Foundation, Hallym University
    Inventors: Soo Young Choi, Dae Won Kim, Sung Ho Lee, Jinseu Park, Won Sik Eum
  • EYE DROP COMPOSITION FOR PREVENTION AND TREATMENT OF OPHTHALMIC DISEASES CONTAINING FUSION PROTEIN OF FK506 BINDING PROTEIN
    Publication number: 20130330368
    Abstract: Disclosed is a treatment for ophthalmic diseases, more specifically, a pharmaceutical composition for treating ophthalmic diseases including a fusion protein of FK506 binding protein capable of penetrating into the ocular tissue as an active ingredient.
    Type: Application
    Filed: April 6, 2011
    Publication date: December 12, 2013
    Applicant: INDUSTRY ACADEIC COOPERATION FOUNDATION, HALLYM UNIVERSITY
    Inventors: Soo Young Choi, Dae Won Kim, Sung Ho Lee, Jinseu Park, Won Sik Eum
  • Fusion protein comprising FK506 binding protein and DNA encoding the same
    Patent number: 7902346
    Abstract: Disclosed is a fusion protein containing a FK506 binding protein and a cell-transducing domain. Also, disclosed is a method of making the fusion protein and use of the fusion protein in a pharmaceutical or cosmetic composition. The cell-transducing domain is, for example, a PEP-1.
    Type: Grant
    Filed: June 24, 2008
    Date of Patent: March 8, 2011
    Assignee: Industry Academic Cooperation Foundation, Hallym University
    Inventors: Soo Young Choi, Jinseu Park, Won Sik Eum, Dae-Won Kim, Jin-Hee Choi, Tae-Yoon Kim, Hyung-Joo Kwon
  • FUSION PROTEIN COMPRISING FK506 BINDING PROTEIN AND METHOD OF MAKING AND USING THE SAME
    Publication number: 20080280830
    Abstract: Disclosed is a fusion protein containing a FK506 binding protein and a cell-transducing domain. Also, disclosed is a method of making the fusion protein and use of the fusion protein in a pharmaceutical or cosmetic composition. The cell-transducing domain is, for example, a PEP-1.
    Type: Application
    Filed: June 24, 2008
    Publication date: November 13, 2008
    Applicant: INDUSTRY ACADEMIC COOPERATION FOUNDATION, HALLYM UNIVERSITY
    Inventors: Soo Young Choi, Jinseu Park, Won Sik Eum, Dae-Won Kim, Jin-Hee Choi, Tae-Yoon Kim, Hyung-Joo Kwon